Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × mirdametinib × 90 days × Clear all

Phase

Status

Recruiting 6 Suspended 1 Not yet recruiting 1 Available 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 1 Glioma 1 Glioblastoma 1

Interventions

Specimen Handling 57 Magnetic Resonance Spectroscopy 43 Carboplatin 37 Cyclophosphamide 32 Cisplatin 30 Gemcitabine 29 Bevacizumab 28 pembrolizumab 27 Capecitabine 27 Paclitaxel 26 Oxaliplatin 26 Biopsy 26 venetoclax 24 Nivolumab 24 tislelizumab 21 fludarabine 21 Standard of Care 21 Drug Therapy 21 Radiotherapy 19 toripalimab 18 Docetaxel 18 Azacitidine 17 cemiplimab 16 Injections 16 Fluorouracil 16 lenvatinib 15 Radiosurgery 14 Pemetrexed 14 Cytarabine 13 Blood Specimen Collection 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07521657 2026-04-13

NF118

University of Alabama at Birmingham

Phase 2 Not yet recruiting

Glioblastoma, Glioma, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡